Neurizon inks $1.5M loan against R&D Tax Rebate
Neurizon Therapeutics (ASX:NUZ) retreated in intra-day trade on Wednesday after inking a non-dilutive loan agreement for $1.5 million to fund its current and future operations seeking to treat Huntington’s with its flagship drug NUZ-001.The funds in question are secured against it...
Currently unlisted.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
RWH | Ann: Ceasing to be a substantial holder from BTT | 06/10/17 | 0 | 1.7K | |||
|
|||||||
RWH | Ann: Removal from Official List | 06/10/17 | 0 | 777 | |||
|
|||||||
RWH | Ann: Ceasing to be a substantial holder | 04/10/17 | 0 | 664 | |||
|
|||||||
RWH | Ann: Ceasing to be a substantial holder from CBA | 04/10/17 | 0 | 519 | |||
|
|||||||
RWH | Ann: Suspension from Official Quotation - cob 3/10/17 | 03/10/17 | 0 | 603 | |||
|
|||||||
RWH | Ann: Notice of compulsory acquisition - GFN | 28/09/17 | 1 | 1.2K | |||
|
|||||||
RWH | Ann: Final Director's Interest Notice | 27/09/17 | 0 | 664 | |||
|
|||||||
RWH | Ann: Final Director's Interest Notice | 27/09/17 | 0 | 604 | |||
|
See All Discussions